Advanced glycation endproducts in serum of patients with chronic hepatitis and liver cirrhosis

Advances in Clinical and Experimental Medicine

Volumn 15, Issue 2, 2006, Pages 259-264

  Zuwała Jagiełło, Jolanta ^a   Simon, Krzysztof ^a   Pazgan Simon, Monika ^a   Kość Czarny, Anna ^a   Warwas, Maria ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Advanced glycation endproducts; Chronic hepatitis; Cirrhosis; Haptoglobin; Neopterin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; HAPTOGLOBIN; NEOPTERIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CARBOHYDRATE ANALYSIS; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PREDICTION; SERUM; STATISTICAL SIGNIFICANCE; VIRUS HEPATITIS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 33744806337     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bataller R, Brenner DA: Liver fibrosis. J Clin Invest 2005, 115, 209-218.
2. Lapolla A, Traldi P, Fedele D: Importance of measuring products of non-enzymatic glycation of proteins. Clin Biochem 2005, 38, 103-115.
3. Rojas A, Morales MA: Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci 2004, 76, 715-730.
4. Arakawa Y, Moriyama M, Arakawa Y: Liver cirrhosis and metabolism sugar, protein, fat and trace elements. Hepatol Res 2004, 30S, S46-S58.
5. Sebekova K, Kupcova V, Schinzel R, Heidland A: Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis-amelioration by liver transplantation. J Hepatol 2002, 36, 66-71.
6. Hoffmann G, Wirleitner B, Fuchs D: Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 2003, 52, 313-321.
7. Berdowska A, Zwirska-Korczala K: Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 2001, 26, 319-329.
8. Myers RP, Benhamou Y, Imbert-Bismut F, Thibault V, Bochet M, Charlotte F, Ratziu V, Bricaire F, Katlama C, Poynard T: Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS 2003, 17, 721-725.
9. Poynard T, Imbert-Bismut F, Munteanu M, Ratziu V: FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis? Expert Rev Mol Diagn 2005, 5, 15-21.
10. Child JG, Turcotte JG: Surgery and portal hypertension. In: The liver and portal hypertension. Eds.: Child CG. WB Saunders. Philadelphia 1964, 50-72.
11. Münch G, Keis R, Wessels A, Riederer P, Bahner U, Heidland A, Niwa T, Lemke HD, Schinzel R: Determination of advanced glycation endproducts in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 1997, 35, 669-677.
12. Jones GE, Mould DL: Adaptation of the guaiacol (peroxidase) test for haptoglobins to a microtitration plate system. Res Vet Sci 1984, 37, 87-92.
13. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH: Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000, 32, 209-217.
14. Ahmed N, Thornalley PJ, Luthen R, Haussinger D, Sebekova K, Schinzel R, Voelker W, Heidland A: Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J Hepatol 2004, 41, 913-919.
15. Li YM, Mitsuhashi T, Wojciechowicz D, Shimizu N, Li Y, Stitt A: Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80-K-H membrane proteins. Proc Natl Acad Sci USA 1996, 93, 11047-11052.
16. Ohgami N, Nagai R, Miyazaki A, Ikemoto A, Arai H, Horiuchi S, Nakayama H: Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End Products. J Biol Chem 2001, 276, 13348-13355.
17. Zuwała-Jagiełło J: Rola kaweoli śródbłonka w endocytozie późnych produktów glikacji. Post Biochem 2004, 3, 272-281.
18. Nakaji M, Hayashi Y, Ninomiya T, Yano Y, Yoon S, Seo Y, Nagano H, Komori H, Hashimoto K, Orino A, Shirane H, Yokozaki H, Kasuga M: Histological grading and staging in chronic hepatitis: its practical correlation. Pathol Int 2002, 52, 683-690.
19. Myers RP, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T: Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C. Am J Gastroenterol 2002, 97, 2419-2425.
20. Homann C, Benfield TL, Graudal NA, Garred P: Neopterin and interleukin-8 prognosis in alcohol-induced cirrhosis. Liver 2000, 20, 442-449.